Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 333 of 333 entries
Sorted by: Best Match Show Resources per page
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).

Pharmacogenetics and genomics

Patel JN, Jiang C, Owzar K, Mulkey F, Luzum JA, Mamon HJ, Haller DG, Dragovich T, Alberts SR, Bjarnason G, Willet CG, Niedzwiecki D, Enzinger P, Ratain MJ, Fuchs C, McLeod HL.
PMID: 34149004
Pharmacogenet Genomics. 2021 Dec 01;31(9):215-220. doi: 10.1097/FPC.0000000000000442.

There is a lack of pharmacogenetic predictors of outcome in gastric cancer patients. The aim of this study was to assess previously identified candidate genes associated with 5-fluorouracil (5-FU), cisplatin, or epirubicin toxicity or response in a cohort of...

Cite
Patel JN, Jiang C, Owzar K, et al. Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenet Genomics. 2021;31(9):215-220doi: 10.1097/FPC.0000000000000442.
Patel, J. N., Jiang, C., Owzar, K., Mulkey, F., Luzum, J. A., Mamon, H. J., Haller, D. G., Dragovich, T., Alberts, S. R., Bjarnason, G., Willet, C. G., Niedzwiecki, D., Enzinger, P., Ratain, M. J., Fuchs, C., & McLeod, H. L. (2021). Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics, 31(9), 215-220. https://doi.org/10.1097/FPC.0000000000000442
Patel, Jai N, et al. "Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)." Pharmacogenetics and genomics vol. 31,9 (2021): 215-220. doi: https://doi.org/10.1097/FPC.0000000000000442
Patel JN, Jiang C, Owzar K, Mulkey F, Luzum JA, Mamon HJ, Haller DG, Dragovich T, Alberts SR, Bjarnason G, Willet CG, Niedzwiecki D, Enzinger P, Ratain MJ, Fuchs C, McLeod HL. Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenet Genomics. 2021 Dec 01;31(9):215-220. doi: 10.1097/FPC.0000000000000442. PMID: 34149004; PMCID: PMC8490297.
Copy Download .nbib Format: NLM
Reply.

Ophthalmology. Retina

Khan MA, Sivalingam A, Haller JA.
PMID: 33814048
Ophthalmol Retina. 2021 Apr;5(4):e6. doi: 10.1016/j.oret.2021.01.007.

No abstract available.

Cite
Khan MA, Sivalingam A, Haller JA. Reply. Ophthalmol Retina. 2021;5(4):e6doi: 10.1016/j.oret.2021.01.007.
Khan, M. A., Sivalingam, A., & Haller, J. A. (2021). Reply. Ophthalmology. Retina, 5(4), e6. https://doi.org/10.1016/j.oret.2021.01.007
Khan, M Ali, et al. "Reply." Ophthalmology. Retina vol. 5,4 (2021): e6. doi: https://doi.org/10.1016/j.oret.2021.01.007
Khan MA, Sivalingam A, Haller JA. Reply. Ophthalmol Retina. 2021 Apr;5(4):e6. doi: 10.1016/j.oret.2021.01.007. PMID: 33814048; PMCID: PMC8012737.
Copy Download .nbib Format: NLM
Paradoxical cognitive trajectories in men from earlier to later adulthood.

Neurobiology of aging

Eglit GML, Elman JA, Panizzon MS, Sanderson-Cimino M, Williams ME, Dale AM, Eyler LT, Fennema-Notestine C, Gillespie NA, Gustavson DE, Hatton SN, Hagler DJ, Hauger RL, Jak AJ, Logue MW, McEvoy LK, McKenzie RE, Neale MC, Puckett O, Reynolds CA, Toomey R, Tu XM, Whitsel N, Xian H, Lyons MJ, Franz CE, Kremen WS.
PMID: 34785406
Neurobiol Aging. 2022 Jan;109:229-238. doi: 10.1016/j.neurobiolaging.2021.10.002. Epub 2021 Oct 14.

Because longitudinal studies of aging typically lack cognitive data from earlier ages, it is unclear how general cognitive ability (GCA) changes throughout the life course. In 1173 Vietnam Era Twin Study of Aging (VETSA) participants, we assessed young adult...

Cite
Eglit GML, Elman JA, Panizzon MS, et al. Paradoxical cognitive trajectories in men from earlier to later adulthood. Neurobiol Aging. 2021;109:229-238doi: 10.1016/j.neurobiolaging.2021.10.002.
Eglit, G. M. L., Elman, J. A., Panizzon, M. S., Sanderson-Cimino, M., Williams, M. E., Dale, A. M., Eyler, L. T., Fennema-Notestine, C., Gillespie, N. A., Gustavson, D. E., Hatton, S. N., Hagler, D. J., Hauger, R. L., Jak, A. J., Logue, M. W., McEvoy, L. K., McKenzie, R. E., Neale, M. C., Puckett, O., Reynolds, C. A., Toomey, R., Tu, X. M., Whitsel, N., Xian, H., Lyons, M. J., Franz, C. E., & Kremen, W. S. (2022). Paradoxical cognitive trajectories in men from earlier to later adulthood. Neurobiology of aging, 109229-238. https://doi.org/10.1016/j.neurobiolaging.2021.10.002
Eglit, Graham M L, et al. "Paradoxical cognitive trajectories in men from earlier to later adulthood." Neurobiology of aging vol. 109 (2022): 229-238. doi: https://doi.org/10.1016/j.neurobiolaging.2021.10.002
Eglit GML, Elman JA, Panizzon MS, Sanderson-Cimino M, Williams ME, Dale AM, Eyler LT, Fennema-Notestine C, Gillespie NA, Gustavson DE, Hatton SN, Hagler DJ, Hauger RL, Jak AJ, Logue MW, McEvoy LK, McKenzie RE, Neale MC, Puckett O, Reynolds CA, Toomey R, Tu XM, Whitsel N, Xian H, Lyons MJ, Franz CE, Kremen WS. Paradoxical cognitive trajectories in men from earlier to later adulthood. Neurobiol Aging. 2022 Jan;109:229-238. doi: 10.1016/j.neurobiolaging.2021.10.002. Epub 2021 Oct 14. PMID: 34785406; PMCID: PMC8715388.
Copy Download .nbib Format: NLM
Primary Chemoradiotherapy for Older Patients With Esophageal Cancer.

JAMA oncology

Eads JR, Haller DG.
PMID: 34351378
JAMA Oncol. 2021 Oct 01;7(10):1451-1452. doi: 10.1001/jamaoncol.2021.2668.

No abstract available.

Cite
Eads JR, Haller DG. Primary Chemoradiotherapy for Older Patients With Esophageal Cancer. JAMA Oncol. 2021;7(10):1451-1452doi: 10.1001/jamaoncol.2021.2668.
Eads, J. R., & Haller, D. G. (2021). Primary Chemoradiotherapy for Older Patients With Esophageal Cancer. JAMA oncology, 7(10), 1451-1452. https://doi.org/10.1001/jamaoncol.2021.2668
Eads, Jennifer R, and Haller, Daniel G. "Primary Chemoradiotherapy for Older Patients With Esophageal Cancer." JAMA oncology vol. 7,10 (2021): 1451-1452. doi: https://doi.org/10.1001/jamaoncol.2021.2668
Eads JR, Haller DG. Primary Chemoradiotherapy for Older Patients With Esophageal Cancer. JAMA Oncol. 2021 Oct 01;7(10):1451-1452. doi: 10.1001/jamaoncol.2021.2668. PMID: 34351378.
Copy Download .nbib Format: NLM
The Patient Dignity Inventory and Dignity-Related Distress among the Critically Ill.

Journal of pain and symptom management

Mergler BD, Goldshore MA, Shea JA, Lane-Fall MB, Hadler RA.
PMID: 34890727
J Pain Symptom Manage. 2021 Dec 07; doi: 10.1016/j.jpainsymman.2021.12.001. Epub 2021 Dec 07.

CONTEXT: Critical illness confers a significant risk of psychological distress, both during and after intensive care unit (ICU) admission. The Patient Dignity Inventory is a 25-item instrument initially designed to measure psychosocial, existential and symptom-related distress in terminally ill...

Cite
Mergler BD, Goldshore MA, Shea JA, et al. The Patient Dignity Inventory and Dignity-Related Distress among the Critically Ill. J Pain Symptom Manage. 2021;doi: 10.1016/j.jpainsymman.2021.12.001.
Mergler, B. D., Goldshore, M. A., Shea, J. A., Lane-Fall, M. B., & Hadler, R. A. (2021). The Patient Dignity Inventory and Dignity-Related Distress among the Critically Ill. Journal of pain and symptom management, . https://doi.org/10.1016/j.jpainsymman.2021.12.001
Mergler, Blake D, et al. "The Patient Dignity Inventory and Dignity-Related Distress among the Critically Ill." Journal of pain and symptom management vol. (2021). doi: https://doi.org/10.1016/j.jpainsymman.2021.12.001
Mergler BD, Goldshore MA, Shea JA, Lane-Fall MB, Hadler RA. The Patient Dignity Inventory and Dignity-Related Distress among the Critically Ill. J Pain Symptom Manage. 2021 Dec 07; doi: 10.1016/j.jpainsymman.2021.12.001. Epub 2021 Dec 07. PMID: 34890727.
Copy Download .nbib Format: NLM
Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age.

Neurobiology of aging

Franz CE, Hatton SN, Elman JA, Warren T, Gillespie NA, Whitsel NA, Puckett OK, Dale AM, Eyler LT, Fennema-Notestine C, Hagler DJ, Hauger RL, McKenzie R, Neale MC, Panizzon MS, Pearce RC, Reynolds CA, Sanderson-Cimino M, Toomey R, Tu XM, Williams M, Xian H, Lyons MJ, Kremen WS.
PMID: 34547718
Neurobiol Aging. 2021 Dec;108:80-89. doi: 10.1016/j.neurobiolaging.2021.08.007. Epub 2021 Aug 19.

We examined the influence of lifestyle on brain aging after nearly 30 years, and tested the hypothesis that young adult general cognitive ability (GCA) would moderate these effects. In the community-dwelling Vietnam Era Twin Study of Aging (VETSA), 431...

Cite
Franz CE, Hatton SN, Elman JA, et al. Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age. Neurobiol Aging. 2021;108:80-89doi: 10.1016/j.neurobiolaging.2021.08.007.
Franz, C. E., Hatton, S. N., Elman, J. A., Warren, T., Gillespie, N. A., Whitsel, N. A., Puckett, O. K., Dale, A. M., Eyler, L. T., Fennema-Notestine, C., Hagler, D. J., Hauger, R. L., McKenzie, R., Neale, M. C., Panizzon, M. S., Pearce, R. C., Reynolds, C. A., Sanderson-Cimino, M., Toomey, R., Tu, X. M., Williams, M., Xian, H., Lyons, M. J., & Kremen, W. S. (2021). Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age. Neurobiology of aging, 10880-89. https://doi.org/10.1016/j.neurobiolaging.2021.08.007
Franz, Carol E, et al. "Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age." Neurobiology of aging vol. 108 (2021): 80-89. doi: https://doi.org/10.1016/j.neurobiolaging.2021.08.007
Franz CE, Hatton SN, Elman JA, Warren T, Gillespie NA, Whitsel NA, Puckett OK, Dale AM, Eyler LT, Fennema-Notestine C, Hagler DJ, Hauger RL, McKenzie R, Neale MC, Panizzon MS, Pearce RC, Reynolds CA, Sanderson-Cimino M, Toomey R, Tu XM, Williams M, Xian H, Lyons MJ, Kremen WS. Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age. Neurobiol Aging. 2021 Dec;108:80-89. doi: 10.1016/j.neurobiolaging.2021.08.007. Epub 2021 Aug 19. PMID: 34547718.
Copy Download .nbib Format: NLM
Perioperative Management of Do-Not-Resuscitate Orders at a Large Academic Health System.

JAMA surgery

Hadler RA, Fatuzzo M, Sahota G, Neuman MD.
PMID: 34550339
JAMA Surg. 2021 Dec 01;156(12):1175-1177. doi: 10.1001/jamasurg.2021.4135.

No abstract available.

Cite
Hadler RA, Fatuzzo M, Sahota G, et al. Perioperative Management of Do-Not-Resuscitate Orders at a Large Academic Health System. JAMA Surg. 2021;156(12):1175-1177doi: 10.1001/jamasurg.2021.4135.
Hadler, R. A., Fatuzzo, M., Sahota, G., & Neuman, M. D. (2021). Perioperative Management of Do-Not-Resuscitate Orders at a Large Academic Health System. JAMA surgery, 156(12), 1175-1177. https://doi.org/10.1001/jamasurg.2021.4135
Hadler, Rachel A, et al. "Perioperative Management of Do-Not-Resuscitate Orders at a Large Academic Health System." JAMA surgery vol. 156,12 (2021): 1175-1177. doi: https://doi.org/10.1001/jamasurg.2021.4135
Hadler RA, Fatuzzo M, Sahota G, Neuman MD. Perioperative Management of Do-Not-Resuscitate Orders at a Large Academic Health System. JAMA Surg. 2021 Dec 01;156(12):1175-1177. doi: 10.1001/jamasurg.2021.4135. PMID: 34550339; PMCID: PMC8459302.
Copy Download .nbib Format: NLM
Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.

Journal of immunology (Baltimore, Md. : 1950)

Hoehn KB, Ramanathan P, Unterman A, Sumida TS, Asashima H, Hafler DA, Kaminski N, Dela Cruz CS, Sealfon SC, Bukreyev A, Kleinstein SH.
PMID: 34049971
J Immunol. 2021 Jun 15;206(12):2785-2790. doi: 10.4049/jimmunol.2100135. Epub 2021 May 28.

Protective immunity against COVID-19 likely depends on the production of SARS-CoV-2-specific plasma cells and memory B cells postinfection or postvaccination. Previous work has found that germinal center reactions are disrupted in severe COVID-19. This may adversely affect long-term immunity...

Cite
Hoehn KB, Ramanathan P, Unterman A, et al. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19. J Immunol. 2021;206(12):2785-2790doi: 10.4049/jimmunol.2100135.
Hoehn, K. B., Ramanathan, P., Unterman, A., Sumida, T. S., Asashima, H., Hafler, D. A., Kaminski, N., Dela Cruz, C. S., Sealfon, S. C., Bukreyev, A., & Kleinstein, S. H. (2021). Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19. Journal of immunology (Baltimore, Md. : 1950), 206(12), 2785-2790. https://doi.org/10.4049/jimmunol.2100135
Hoehn, Kenneth B, et al. "Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19." Journal of immunology (Baltimore, Md. : 1950) vol. 206,12 (2021): 2785-2790. doi: https://doi.org/10.4049/jimmunol.2100135
Hoehn KB, Ramanathan P, Unterman A, Sumida TS, Asashima H, Hafler DA, Kaminski N, Dela Cruz CS, Sealfon SC, Bukreyev A, Kleinstein SH. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19. J Immunol. 2021 Jun 15;206(12):2785-2790. doi: 10.4049/jimmunol.2100135. Epub 2021 May 28. PMID: 34049971; PMCID: PMC8627528.
Copy Download .nbib Format: NLM
Microstructural development from 9 to 14 years: Evidence from the ABCD Study.

Developmental cognitive neuroscience

Palmer CE, Pecheva D, Iversen JR, Hagler DJ, Sugrue L, Nedelec P, Fan CC, Thompson WK, Jernigan TL, Dale AM.
PMID: 34896850
Dev Cogn Neurosci. 2021 Dec 03;53:101044. doi: 10.1016/j.dcn.2021.101044. Epub 2021 Dec 03.

During late childhood behavioral changes, such as increased risk-taking and emotional reactivity, have been associated with the maturation of cortico-cortico and cortico-subcortical circuits. Understanding microstructural changes in both white matter and subcortical regions may aid our understanding of how...

Cite
Palmer CE, Pecheva D, Iversen JR, et al. Microstructural development from 9 to 14 years: Evidence from the ABCD Study. Dev Cogn Neurosci. 2021;53:101044doi: 10.1016/j.dcn.2021.101044.
Palmer, C. E., Pecheva, D., Iversen, J. R., Hagler, D. J., Sugrue, L., Nedelec, P., Fan, C. C., Thompson, W. K., Jernigan, T. L., & Dale, A. M. (2021). Microstructural development from 9 to 14 years: Evidence from the ABCD Study. Developmental cognitive neuroscience, 53101044. https://doi.org/10.1016/j.dcn.2021.101044
Palmer, Clare E, et al. "Microstructural development from 9 to 14 years: Evidence from the ABCD Study." Developmental cognitive neuroscience vol. 53 (2021): 101044. doi: https://doi.org/10.1016/j.dcn.2021.101044
Palmer CE, Pecheva D, Iversen JR, Hagler DJ, Sugrue L, Nedelec P, Fan CC, Thompson WK, Jernigan TL, Dale AM. Microstructural development from 9 to 14 years: Evidence from the ABCD Study. Dev Cogn Neurosci. 2021 Dec 03;53:101044. doi: 10.1016/j.dcn.2021.101044. Epub 2021 Dec 03. PMID: 34896850; PMCID: PMC8671104.
Copy Download .nbib Format: NLM
Showing 325 to 333 of 333 entries